These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36354089)

  • 1. Synthesis of novel azasugar-containing 2'β-C-Me 9-deaza nucleosides as potential anti-hepatitis C virus agents.
    Kotian PL; Wu M; Ghosh A; Polach KJ; El-Kattan Y; Kumar VS; Lin TH; Cheng X; Bantia S; Raman K; Chand P; Babu YS
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(4):317-327. PubMed ID: 36354089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel 4'α-trifluoromethyl-2'β-C-methyl-carbodine analogs as anti-hepatitis C virus agents.
    Kim S; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(2):79-91. PubMed ID: 25621702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerases.
    Wu M; Vadlakonda S; El-Kattan Y; Ghosh A; Lin TH; Chambers-Wilson R; Cheng X; Bantia S; Kellogg-Yelder D; Chand P; Babu YS; Kotian PL
    Eur J Med Chem; 2024 Jan; 264():115991. PubMed ID: 38118393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside analog inhibitors of hepatitis C virus replication.
    Carroll SS; Olsen DB
    Infect Disord Drug Targets; 2006 Mar; 6(1):17-29. PubMed ID: 16787301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of 1'-C-cyano-2'-fluoro-2'-C-methyl pyrimidine nucleosides as HCV polymerase inhibitors.
    Kirschberg TA; Mish MR; Zhang L; Squires NH; Wang KY; Cho A; Feng JY; Fenaux M; Babusis D; Park Y; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1040-3. PubMed ID: 25650256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
    Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
    J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-HCV activity of 3',4'-oxetane nucleosides.
    Chang W; Du J; Rachakonda S; Ross BS; Convers-Reignier S; Yau WT; Pons JF; Murakami E; Bao H; Steuer HM; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4539-43. PubMed ID: 20580554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs.
    Madela K; McGuigan C
    Future Med Chem; 2012 Apr; 4(5):625-50. PubMed ID: 22458682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase.
    Ehteshami M; Zhou L; Amiralaei S; Shelton JR; Cho JH; Zhang H; Li H; Lu X; Ozturk T; Stanton R; Amblard F; McBrayer TR; Coats SJ; Schinazi RF
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients.
    Cho A; Zhang L; Xu J; Lee R; Butler T; Metobo S; Aktoudianakis V; Lew W; Ye H; Clarke M; Doerffler E; Byun D; Wang T; Babusis D; Carey AC; German P; Sauer D; Zhong W; Rossi S; Fenaux M; McHutchison JG; Perry J; Feng J; Ray AS; Kim CU
    J Med Chem; 2014 Mar; 57(5):1812-25. PubMed ID: 23547794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral properties of novel tetracyclic nucleoside inhibitors of hepatitis C NS5B polymerase.
    Di Francesco ME; Avolio S; Dessole G; Koch U; Pompei M; Pucci V; Rowley M; Summa V
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(8):592-607. PubMed ID: 22908950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues.
    Brown NA
    Expert Opin Investig Drugs; 2009 Jun; 18(6):709-25. PubMed ID: 19426125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
    Draffan AG; Frey B; Fraser BH; Pool B; Gannon C; Tyndall EM; Cianci J; Harding M; Lilly M; Hufton R; Halim R; Jahangiri S; Bond S; Jeynes TP; Nguyen VT; Wirth V; Luttick A; Tilmanis D; Pryor M; Porter K; Morton CJ; Lin B; Duan J; Bethell RC; Kukolj G; Simoneau B; Tucker SP
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4984-8. PubMed ID: 25288185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.
    Olsen DB; Eldrup AB; Bartholomew L; Bhat B; Bosserman MR; Ceccacci A; Colwell LF; Fay JF; Flores OA; Getty KL; Grobler JA; LaFemina RL; Markel EJ; Migliaccio G; Prhavc M; Stahlhut MW; Tomassini JE; MacCoss M; Hazuda DJ; Carroll SS
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3944-53. PubMed ID: 15388457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
    Oh CH; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees.
    Carroll SS; Ludmerer S; Handt L; Koeplinger K; Zhang NR; Graham D; Davies ME; MacCoss M; Hazuda D; Olsen DB
    Antimicrob Agents Chemother; 2009 Mar; 53(3):926-34. PubMed ID: 19075052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conformational mimetic approach for the synthesis of carbocyclic nucleosides as anti-HCV leads.
    Kasula M; Balaraju T; Toyama M; Thiyagarajan A; Bal C; Baba M; Sharon A
    ChemMedChem; 2013 Oct; 8(10):1673-80. PubMed ID: 23943612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3'-deoxysugar analogue as potential anti-hepatitis C virus agents.
    Wang P; Hollecker L; Pankiewicz KW; Patterson SE; Whitaker T; McBrayer TR; Tharnish PM; Stuyver LJ; Schinazi RF; Otto MJ; Watanabe KA
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):957-60. PubMed ID: 16248071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.
    Rondla R; Coats SJ; McBrayer TR; Grier J; Johns M; Tharnish PM; Whitaker T; Zhou L; Schinazi RF
    Antivir Chem Chemother; 2009 Oct; 20(2):99-106. PubMed ID: 19843980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents.
    Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.